MicroRNA‑1323 serves as a biomarker in gestational diabetes mellitus and aggravates high glucose‑induced inhibition of trophoblast cell viability by suppressing TP53INP1

Liu,Lijun; Zhang,Jun; Liu,Yujuan

doi:10.3892/etm.2021.9661

MicroRNA‑1323 serves as a biomarker in gestational diabetes mellitus and aggravates high glucose‑induced inhibition of trophoblast cell viability by suppressing TP53INP1

Authors:
- Lijun Liu
- Jun Zhang
- Yujuan Liu
View Affiliations

Affiliations: Department of Gynecology, Weifang Maternal and Child Health Hospital, Weifang, Shandong 261011, P.R. China, Department of Pharmacy, Weifang Maternal and Child Health Hospital, Weifang, Shandong 261011, P.R. China, Department of Central Supply Room, Weifang Maternal and Child Health Hospital, Weifang, Shandong 261011, P.R. China
Published online on: January 20, 2021 https://doi.org/10.3892/etm.2021.9661
Article Number: 230
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gestational diabetes mellitus (GDM) leads to poor pregnancy outcomes, and microRNAs (miRNAs/miRs) have been suggested to be associated with GDM, but the pathological mechanisms remain unclear. The present study aimed to investigate the diagnostic value of miR‑1323 in GDM patients and its effects on trophoblast cell viability. Additionally, the present study investigated the correlation between miR‑1323 and TP53INP1 to understand the pathological mechanism of GDM progression. Reverse transcription‑quantitative polymerase chain reaction was used to detect the miR‑1323 expression and TP53INP1 mRNA expression. The diagnostic value of serum miR‑1323 was evaluated by receiver operating characteristic analysis. HTR‑8/SVneo and BeWo cells were treated with high glucose (HG) to construct cell models of GDM, and trophoblast cell viability was assessed using an MTT assay. The protein expression of TP53INP1 was detected by western blot analysis. The correlation between miR‑1323 and TP53INP1 was investigated by luciferase reporter assay. The miR‑1323 expression was increased in patients with GDM, which had relatively high diagnostic accuracy for GDM screening and was positively correlated with fasting blood glucose in patients GDM. HG upregulated the miR‑1323 expression and inhibited trophoblast cell viability. Overexpression of miR‑1323 significantly inhibited the viability of HG‑induced trophoblast cells. TP53INP1, a target gene of miR‑1323, was negatively correlated with miR‑1323. TP53INP1 overexpression reversed the inhibitory effect of miR‑1323 overexpression on the viability of HG‑treated trophoblast cells. Increased levels of serum miR‑1323 may be a diagnostic biomarker for GDM. Additionally, miR‑1323 may inhibit trophoblast cell viability by inhibiting TP53INP1, suggesting that it may be a potential therapeutic target for GDM.

View Figures

View References

1	Chiefari E, Arcidiacono B, Foti D and Brunetti A: Gestational diabetes mellitus: An updated overview. J Endocrinol Invest. 40:899–909. 2017.PubMed/NCBI View Article : Google Scholar
2	Lavery JA, Friedman AM, Keyes KM, Wright JD and Ananth CV: Gestational diabetes in the United States: Temporal changes in prevalence rates between 1979 and 2010. BJOG. 124:804–813. 2017.PubMed/NCBI View Article : Google Scholar
3	Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 190: Gestational diabetes mellitus. Obstet Gynecol. 131:e49–e64. 2018.PubMed/NCBI View Article : Google Scholar
4	Yung HW, Alnaes-Katjavivi P, Jones CJ, El-Bacha T, Golic M, Staff AC and Burton GJ: Placental endoplasmic reticulum stress in gestational diabetes: The potential for therapeutic intervention with chemical chaperones and antioxidants. Diabetologia. 59:2240–2250. 2016.PubMed/NCBI View Article : Google Scholar
5	Edu A, Teodorescu C, Dobjanschi CG, Socol ZZ, Teodorescu V, Matei A, Albu DF and Radulian G: Placenta changes in pregnancy with gestational diabetes. Rom J Morphol Embryol. 57:507–512. 2016.PubMed/NCBI View Article : Google Scholar
6	Wang Y, Ji L, Peng Z, Lai R, Zhang X, Xu Y, Chen Z, Liu R, Zhong Y, Hu H and Wang L: Silencing DAPK3 blocks the autophagosome-lysosome fusion by mediating SNAP29 in trophoblast cells under high glucose treatment. Mol Cell Endocrinol. 502(110674)2020.PubMed/NCBI View Article : Google Scholar
7	Chang SC and Vivian Yang WC: Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast. Evid Based Complement Alternat Med. 2013(457971)2013.PubMed/NCBI View Article : Google Scholar
8	Zong S, Li C, Luo C, Zhao X, Liu C, Wang K, Jia W, Bai M, Yin M, Bao S, et al: Dysregulated expression of IDO may cause unexplained recurrent spontaneous abortion through suppression of trophoblast cell proliferation and migration. Sci Rep. 6(19916)2016.PubMed/NCBI View Article : Google Scholar
9	Tian FJ, Qin CM, Li XC, Wu F, Liu XR, Xu WM and Lin Y: Decreased stathmin-1 expression inhibits trophoblast proliferation and invasion and is associated with recurrent miscarriage. Am J Pathol. 185:2709–2721. 2015.PubMed/NCBI View Article : Google Scholar
10	Gao Y, She R, Wang Q, Li Y and Zhang H: Up-regulation of miR-299 suppressed the invasion and migration of HTR-8/SVneo trophoblast cells partly via targeting HDAC2 in pre-eclampsia. Biomed Pharmacother. 97:1222–1228. 2018.PubMed/NCBI View Article : Google Scholar
11	Dias S, Pheiffer C, Abrahams Y, Rheeder P and Adam S: Molecular biomarkers for gestational diabetes mellitus. Int J Mol Sci. 19(2926)2018.PubMed/NCBI View Article : Google Scholar
12	Tryggestad JB, Vishwanath A, Jiang S, Mallappa A, Teague AM, Takahashi Y, Thompson DM and Chernausek SD: Influence of gestational diabetes mellitus on human umbilical vein endothelial cell miRNA. Clin Sci (Lond). 130:1955–1967. 2016.PubMed/NCBI View Article : Google Scholar
13	Pheiffer C, Dias S, Rheeder P and Adam S: Decreased expression of circulating miR-20a-5p in South African women with gestational diabetes mellitus. Mol Diagn Ther. 22:345–352. 2018.PubMed/NCBI View Article : Google Scholar
14	Yoffe L, Polsky A, Gilam A, Raff C, Mecacci F, Ognibene A, Crispi F, Gratacós E, Kanety H, Mazaki-Tovi S, et al: Early diagnosis of gestational diabetes mellitus using circulating microRNAs. Eur J Endocrinol. 181:565–577. 2019.PubMed/NCBI View Article : Google Scholar
15	Gillet V, Ouellet A, Stepanov Y, Rodosthenous RS, Croft EK, Brennan K, Abdelouahab N, Baccarelli A and Takser L: miRNA profiles in extracellular vesicles from serum early in pregnancies complicated by gestational diabetes mellitus. J Clin Endocrinol Metab. 104:5157–5169. 2019.PubMed/NCBI View Article : Google Scholar
16	Na Q, Wang D and Song W: Underexpression of 4 placenta-associated microRNAs in complete hydatidiform moles. Int J Gynecol Cancer. 22:1075–1080. 2012.PubMed/NCBI View Article : Google Scholar
17	Seillier M, Pouyet L, N'Guessan P, Nollet M, Capo F, Guillaumond F, Peyta L, Dumas JF, Varrault A, Bertrand G, et al: Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1. EMBO Mol Med. 7:802–818. 2015.PubMed/NCBI View Article : Google Scholar
18	Zhang F, Yang C, Xing Z, Liu P, Zhang B, Ma X, Huang L and Zhuang L: LncRNA GAS5-mediated miR-1323 promotes tumor progression by targeting TP53INP1 in hepatocellular carcinoma. Onco Targets Ther. 12:4013–4023. 2019.PubMed/NCBI View Article : Google Scholar
19	American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabet Care. 35 (Suppl 1):S64–S71. 2012.
20	Tiongco RE, Bituin A, Arceo E, Rivera N and Singian E: Salivary glucose as a non-invasive biomarker of type 2 diabetes mellitus. J Clin Exp Dent. 10:e902–e907. 2018.PubMed/NCBI View Article : Google Scholar
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
22	Chen X, Gong Y, Zhang DH, You ZH and Li ZW: DRMDA: Deep representations-based miRNA-disease association prediction. J Cell Mol Med. 22:472–485. 2018.PubMed/NCBI View Article : Google Scholar
23	Fang M, Li Y, Wu Y, Ning Z, Wang X and Li X: miR-185 silencing promotes the progression of atherosclerosis via targeting stromal interaction molecule 1. Cell Cycle. 18:682–695. 2019.PubMed/NCBI View Article : Google Scholar
24	Liu Y, Bi X, Xiong J, Han W, Xiao T, Xu X, Yang K, Liu C, Jiang W, He T, et al: MicroRNA-34a promotes renal fibrosis by downregulation of klotho in tubular epithelial cells. Mol Ther. 27:1051–1065. 2019.PubMed/NCBI View Article : Google Scholar
25	Zhou X, Xiang C and Zheng X: miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability. Diagn Pathol. 14(119)2019.PubMed/NCBI View Article : Google Scholar
26	Qi S and Wang X: Decreased expression of miR-185 in serum and placenta of patients with gestational diabetes mellitus. Clin Lab. 65:2019.PubMed/NCBI View Article : Google Scholar
27	Bertoli G, Cava C and Castiglioni I: The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer. Scand J Clin Lab Invest Suppl. 245 (Suppl 1):S34–S39. 2016.PubMed/NCBI View Article : Google Scholar
28	Yang M, Zhao L and Sun M: Diagnostic value of miR-103 in patients with sepsis and noninfectious SIRS and its regulatory role in LPS-induced inflammatory response by targeting TLR4. Int J Genomics. 2020(2198308)2020.PubMed/NCBI View Article : Google Scholar
29	Liu W, Zhao X, Zhang YJ, Fang GW and Xue Y: MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma. J Int Med Res. 46:975–983. 2018.PubMed/NCBI View Article : Google Scholar
30	Zhao H, Zheng C, Wang Y, Hou K, Yang X, Cheng Y, Che X, Xie S, Wang S, Zhang T, et al: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker. Front Oncol. 10(181)2020.PubMed/NCBI View Article : Google Scholar
31	Xu Y and Liu M: MicroRNA-1323 downregulation promotes migration and invasion of breast cancer cells by targeting tumor protein D52. J Biochem. 168:83–91. 2020.PubMed/NCBI View Article : Google Scholar
32	Peng HY, Li MQ and Li HP: High glucose suppresses the viability and proliferation of HTR8/SVneo cells through regulation of the miR137/PRKAA1/IL6 axis. Int J Mol Med. 42:799–810. 2018.PubMed/NCBI View Article : Google Scholar
33	Ji L and Li X: Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211. J Cell Physiol. 234:22911–22920. 2019.PubMed/NCBI View Article : Google Scholar
34	Peng HY, Li MQ and Li HP: miR-137 restricts the viability and migration of HTR-8/SVneo cells by downregulating FNDC5 in gestational diabetes mellitus. Curr Mol Med. 19:494–505. 2019.PubMed/NCBI View Article : Google Scholar
35	Nishimoto M, Nishikawa S, Kondo N, Wanifuchi-Endo Y, Hato Y, Hisada T, Dong Y, Okuda K, Sugiura H, Kato H, et al: Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients. Jpn J Clin Oncol. 49:567–575. 2019.PubMed/NCBI View Article : Google Scholar
36	Du J, Yang ST, Liu J, Zhang KX and Leng JY: Silence of LncRNA GAS5 protects cardiomyocytes H9c2 against hypoxic injury via sponging miR-142-5p. Mol Cells. 42:397–405. 2019.PubMed/NCBI View Article : Google Scholar
37	Li N, Cui T, Guo W, Wang D and Mao L: miR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1. Onco Targets Ther. 12:3181–3196. 2019.PubMed/NCBI View Article : Google Scholar
38	Ye W, Liang F, Ying C, Zhang M, Feng D and Jiang X: Downregulation of microRNA-3934-5p induces apoptosis and inhibits the proliferation of neuroblastoma cells by targeting TP53INP1. Exp Ther Med. 18:3729–3736. 2019.PubMed/NCBI View Article : Google Scholar
39	Dou J, Tu D, Zhao H and Zhang X: LncRNA PCAT18/miR-301a/TP53INP1 axis is involved in gastric cancer cell viability, migration, and invasion. J Biochem. 168:547–555. 2020.PubMed/NCBI View Article : Google Scholar
40	Abou-Kheir W, Barrak J, Hadadeh O and Daoud G: HTR-8/SVneo cell line contains a mixed population of cells. Placenta. 50:1–7. 2017.PubMed/NCBI View Article : Google Scholar